Crescita Therapeutics (TSE:CTX) Sets New 12-Month High – What’s Next?

Crescita Therapeutics Inc. (TSE:CTX)’s stock price reached a new 52-week high on Monday . The stock traded as high as C$0.76 and last traded at C$0.76, with a volume of 9067 shares changing hands. The stock had previously closed at C$0.76.

Crescita Therapeutics Price Performance

The business has a fifty day moving average price of C$0.67 and a two-hundred day moving average price of C$0.54. The company has a current ratio of 3.33, a quick ratio of 2.29 and a debt-to-equity ratio of 2.14. The company has a market cap of C$14.15 million, a price-to-earnings ratio of 37.50 and a beta of -1.34.

Crescita Therapeutics (TSE:CTX) last posted its quarterly earnings results on Monday, May 11th. The company reported C($0.06) EPS for the quarter. Crescita Therapeutics had a negative return on equity of 0.59% and a negative net margin of 0.44%.The company had revenue of C$5.64 million for the quarter.

Crescita Therapeutics Company Profile

Crescita Therapeutics Inc is a Canadian commercial dermatology company with in-house research & development and manufacturing capabilities. The company offers a portfolio of non-prescription skincare products and early to commercial-stage prescription drug products and owns multiple proprietary drug delivery platforms that support the development of patented formulations that can facilitate the delivery of active ingredients into or through the skin. The firm generates its revenue in the form of product sales and out-licensing revenue.